Tegaserod
- 1 January 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 34 (1) , 27-33
- https://doi.org/10.1097/00004836-200201000-00006
Abstract
Tegaserod is a medication that has been shown to be of benefit in women with irritable bowel syndrome (IBS) associated with abdominal pain, bloating, and constipation. Tegaserod is a selective serotonin receptor subtype 4 partial agonist designed to interact with the network of cells and nerves throughout the gastrointestinal tract that use serotonin. Tegaserod has been shown to modulate both gastrointestinal motility and visceral sensitivity. Specifically, it increases the peristaltic reflex and decreases visceral sensitivity. Clinical studies have shown that tegaserod improves symptoms of abdominal pain, bloating, and constipation in women with IBS. This article discusses the role of serotonin in gastrointestinal tract physiology, the structure and pharmacokinetic profile of tegaserod, and clinical applications of this new drug.Keywords
This publication has 33 references indexed in Scilit:
- Tegaserod (HTF 919) does not decrease the effectiveness of an oral contraceptive when coadministered to healthy female subjectsGastroenterology, 2000
- Tegaserod does not significantly affect the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsGastroenterology, 2000
- Tegaserod, a 5-HT4 receptor partial agonist, relieves key symptoms of irritable bowel syndrome (IBS)Gastroenterology, 2000
- Tegaseroid (HTF 919), a partial 5-HT4 receptor agonist, accelerates gastrointestinal (GI) transitGastroenterology, 2000
- Antinociceptive properties of HTF 919 (tegaserod), a 5-HT4 receptor partial agonist, on colorectal distension in ratsGastroenterology, 2000
- Having an impact: Gastroenterology—the journalGastroenterology, 1999
- Investigations on a 5HT4 agonist (SDZ HTF 919) and its main metabolite in conscious dogs: Effects on gastrointestinal motility and impaired gastric emptyingGastroenterology, 1998
- In vivo modulation of left colonic motor function by a 5HT4 mechanism in healthy humansGastroenterology, 1998
- First Pharmacokinetic—Pharmacodynamic Study in Humans with a Selective 5‐Hydroxytryptamine4 Receptor AgonistThe Journal of Clinical Pharmacology, 1997
- The Serotonin 5-HT4 Receptor. 1. Design of a New Class of Agonists and Receptor Map of the Agonist Recognition SiteJournal of Medicinal Chemistry, 1995